Posts
-
Deploying Polygenic Risk Scores in Primary Care Settings
A multi-institutional team of investigators have developed a new framework for supporting healthcare providers in implementing polygenic risk score-based testing into primary care settings, according to a recent study published in Nature Medicine.
-
Trailblazing Biochemist Delivers Kimberly Prize Lecture
Influential biochemist Craig M. Crews, PhD, who pioneered the pharmaceutical field of targeted protein degradation, delivered the second Kimberly Prize in Biochemistry and Molecular Genetics Lecture to a full auditorium of Feinberg faculty, staff, fellows and students.
-
‘Polypills’ Can Help Patients Reduce Heart Disease Risk
Combining multiple heart disease drugs into a single “polypill” can lower bad cholesterol and blood pressure, boost medication adherence, and reduce the risk of cardiovascular disease and death, according to a meta-analysis of recent clinical trials published in Nature Medicine.